Martin Brenner - 23 Aug 2023 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Chief Executive Officer and Chief Scientific Officer
Signature
/s/ Martin Brenner
Issuer symbol
IBIO
Transactions as of
23 Aug 2023
Net transactions value
$0
Form type
4
Filing time
24 Aug 2023, 16:02:53 UTC
Previous filing
28 Jul 2023
Next filing
30 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +120,000 $0.000000 120,000 23 Aug 2023 Common Stock 120,000 $0.3459 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

Remarks:

Chief Executive Officer and Chief Scientific Officer